Healthpeak Properties, Inc. logo

Healthpeak Properties, Inc. (DOC)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
22. 51
+0.18
+0.8061%
$
14.93B Market Cap
30.93 P/E Ratio
1.22% Div Yield
7.03M Volume
0.39 Eps
$ 22.33
Previous Close
Add Transaction
Day Range
22.27 22.62
Year Range
15.7 22.62
Want to track DOC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Healthpeak Properties Stock Up 13.5% in a Month: Will the Trend Last?

Healthpeak Properties Stock Up 13.5% in a Month: Will the Trend Last?

DOC shares rise 13.5% in a month as lab demand, senior care growth and $925M in deals highlight its capital strategy.

Zacks | 5 months ago
Healthpeak Properties: San Francisco Is Recovering - But Monetization, Not Exposure, Determines The Right REIT

Healthpeak Properties: San Francisco Is Recovering - But Monetization, Not Exposure, Determines The Right REIT

Healthpeak Properties has concentrated exposure to South San Francisco life-science assets, allowing it to benefit from the region's innovation-led recovery without relying on downtown office demand. DOC's portfolio is diversified nationally, with 23% of NOI coming from San Francisco while Outpatient Medical assets provide the majority of stable cash flow. The portfolio has a 7.3-year average lease term, with longer Outpatient Medical leases providing stability and shorter Lab leases allowing faster adjustment as leasing conditions improve.

Seekingalpha | 6 months ago
Healthpeak Monetizes Senior Housing Assets Through Janus Living IPO

Healthpeak Monetizes Senior Housing Assets Through Janus Living IPO

DOC aims to unlock value in its senior housing platform by spinning out Janus Living via an IPO while retaining control and recurring management income.

Zacks | 6 months ago
Healthpeak Properties: Weighing Lab Pressure Against Long-Term Fundamentals

Healthpeak Properties: Weighing Lab Pressure Against Long-Term Fundamentals

Healthpeak Properties remains a contrarian, long-term opportunity, with management focused on capital allocation, a covered dividend, and technology-driven efficiencies. DOC plans to recycle $1B+ from outpatient medical asset sales into higher-return lab assets, targeting double-digit unlevered IRRs despite near-term sector headwinds. Lab and outpatient segments show improving leasing pipelines, with occupancy expected to bottom in the high 70s before recovery, while CCRC delivers strong NOI growth.

Seekingalpha | 6 months ago
Here's Why Healthpeak (DOC) is a Strong Value Stock

Here's Why Healthpeak (DOC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 6 months ago
3 New Year's Resolution Stocks That Could Turn Around in 2026

3 New Year's Resolution Stocks That Could Turn Around in 2026

At the start of the new year, investors seeking a fresh approach might consider stocks that are positioned for a reset. Companies trading at or near their lowest level for 2025 could be primed for gains in the new year if conditions are right.

Marketbeat | 7 months ago
More Rate Cuts Are Coming in 2026: Grab These Safe 7% and 8% Dividend Stocks Now

More Rate Cuts Are Coming in 2026: Grab These Safe 7% and 8% Dividend Stocks Now

The September inflation reading of 3% represents moderate price growth, which is above the Federal Reserve's long-term target of 2% but well below the elevated rates seen in 2022 and early 2023.

247wallst | 7 months ago
Healthpeak Properties: Buy This 7% Yield Before The Market Rotates To Value

Healthpeak Properties: Buy This 7% Yield Before The Market Rotates To Value

Healthpeak Properties is deeply undervalued, trading at just 9.1x forward P/FFO and offering a 7.3% dividend yield. DOC benefits from strong fundamentals in outpatient medical and senior housing, with same-store NOI growth and robust re-leasing spreads. Management is executing $1 billion in asset sales, tightening cost controls, and targeting double-digit unlevered IRRs on new investments.

Seekingalpha | 7 months ago
Why Healthpeak (DOC) is a Top Value Stock for the Long-Term

Why Healthpeak (DOC) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 7 months ago
Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential

Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.

247wallst | 7 months ago
Healthpeak Properties: Healthcare REIT Paying Monthly Dividends, Solid Recovery Potential

Healthpeak Properties: Healthcare REIT Paying Monthly Dividends, Solid Recovery Potential

Healthpeak Properties maintains a Buy rating, offering a ~6.7% sustainable monthly dividend yield and strong potential for recovery as industry headwinds could ease. DOC reported robust Q3 results, with solid AFFO, solid asset recycling, conservative balance sheet management, and a significant pipeline for higher-return lab investments. Near-term catalysts include the Fed's rate cuts and asset recycling advancing, while macro uncertainty and lab occupancy declines may cause short-term volatility for DOC.

Seekingalpha | 7 months ago
3 Best Monthly Paying Dividend Stocks in the S&P 500

3 Best Monthly Paying Dividend Stocks in the S&P 500

All of us could benefit from a little extra income every month, and many dividend investors look for passive income through dividend stocks.

247wallst | 7 months ago
Loading...
Load More